Completed OBSERVATIONAL NCT02255851

Sentinel(TM) Post-Market Registry

Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement

Sponsor: Claret Medical

Conditions Severe Symptomatic Calcified Native Aortic Valve Stenosis Transcatheter Aortic Valve Replacement

Interventions SENTINEL (Cerebral Protection System)

Updated 11 times since 2017 Last updated: May 22, 2018 Started: Mar 31, 2014 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Severe Symptomatic Calcified Native Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement, this trial is completed. The trial is conducted by Claret Medical and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed

Status: Unknown Status → Completed
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Feb 2017 — Aug 2017 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Claret Medical

Data source: Claret Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.